Insider Shareholders with Direct Ownership of Akari Therapeutics PLC (AKTX)
This section provides a comprehensive overview of the insiders with direct ownership of Akari Therapeutics PLC (AKTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Akari Therapeutics Plc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Rachelle Suzanne Jacques
Chief Executive Officer |
479,569,892 | 0 | 1,018,027,792 $529 Million | 1 |
Apr 26, 2024
Added 32.02%
|
|
Wendy F Dicicco
Interim CFO |
158,473,915 | 0 | 158,473,915 $82.4 Million | 1 |
May 01, 2024
Added 50.0%
|
|
Samir Rashmikant Patel
Director |
91,396,000 | 0 | 91,396,000 $47.5 Million | 1 |
Jun 30, 2024
Added 50.0%
|
|
Hoyoung Huh
Director |
892,857 | 0 | 4,695,854 $2.44 Million | 1 |
Mar 06, 2025
Added 15.98%
|
|
Raymond Prudo Chlebosz
Director |
419,732,428 | 0 | 2,484,990 $1.29 Million | 3 |
Mar 06, 2025
Added 15.23%
|
|
Sandip I Patel
Director |
44,642 | 0 | 496,499 $258,179 | 1 |
Mar 06, 2025
Added 8.25%
|
| 71,982,513 | 0 | 298,574 $155,258 | 15 |
Aug 25, 2025
Added 0.99%
|
|
|
Robert B Bazemore
Director |
44,642 | 0 | 44,642 $23,213 | 1 |
Mar 06, 2025
Added 50.0%
|
| 10,004,464 | 0 | 36,271 $18,860 | 3 |
Mar 06, 2025
Added 10.96%
|
|
|
Kameel D. Farag
Interim CFO |
64,896 | 0 | 26,619 $13,841 | 2 |
Nov 01, 2025
Added 50.0%
|
|
Torsten Hombeck
CFO |
200 | 0 | 200 $104 | 1 |
Jan 10, 2025
Added 50.0%
|